DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Raised to $25.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price raised by stock analysts at Needham & Company LLC from $23.00 to $25.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Needham & Company LLC’s price objective would indicate a potential upside of 27.36% from the stock’s current price.

Other analysts have also issued reports about the stock. Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. UBS Group reduced their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research report on Tuesday, December 3rd. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Barrington Research dropped their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Ten investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $26.33.

DENTSPLY SIRONA Trading Up 0.1 %

Shares of NASDAQ XRAY opened at $19.63 on Thursday. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $35.42. The firm has a market cap of $3.90 billion, a PE ratio of -9.48, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The business has a fifty day simple moving average of $19.09 and a two-hundred day simple moving average of $22.55. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 earnings per share. Analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Large investors have recently made changes to their positions in the company. Nordea Investment Management AB increased its holdings in DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock valued at $4,754,000 after buying an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Barclays PLC raised its holdings in DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after purchasing an additional 54,920 shares during the period. Quantinno Capital Management LP boosted its position in DENTSPLY SIRONA by 276.5% during the third quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier’s stock worth $3,161,000 after purchasing an additional 85,787 shares in the last quarter. Finally, VELA Investment Management LLC purchased a new position in DENTSPLY SIRONA during the third quarter worth approximately $2,168,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.